I-99. A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients with platinum refractory or resistant non-small cell lung cancer (NSCLC)
Titel:
I-99. A phase II efficacy study of brostallicin, a novel minor groove binder (MGB), in patients with platinum refractory or resistant non-small cell lung cancer (NSCLC)
Auteur:
Sandler, A. Natale, R. Blajman, C. Kalemkerian, G. Drinkard, L. Fein, L. Campbell, A. Polli, A. Vreeland, F. Hirawat, S.